Dermatology Times - "Experimental Oral Drug May Be Effective In Treating Metastatic Basal Cell Carcinoma"

 – October 1, 2011 /Press Release/  –– 

A new experimental oral medication is proving highly effective in the treatment of metastatic basal cell carcinoma (BCC), according to a recent study. Dr. Ellen Marmur, associate professor and chief of the division of dermatologic & cosmetic surgery at The Mount Sinai Medical Center was a co-investigator in a recent phase 2 trial that evaluated the efficacy and safety of vismodegib in patients with advanced BCC. Learn more.